New cytotoxic drugs in clinical development.
Extra
J M
JM
Service d'Oncologie Médicale, Hôpital Saint-Louis, Paris, France.
Rousseau
F
F
Culine
S
S
Giacchetti
S
S
Madelaine
I
I
Marty
M
M
D000470:Alkaloids / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D002166:Camptothecin / Q000031:analogs & derivatives / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D000077143:Docetaxel; D006801:Humans; D017239:Paclitaxel; D043823:Taxoids; D019772:Topotecan
D000470:Alkaloids; D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D019772:Topotecan; D017239:Paclitaxel; D002166:Camptothecin